LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 54

Search options

  1. Article ; Online: Sex-dependent effects of acute stress on amyloid-β in male and female mice.

    Edwards, Hannah M / Wallace, Clare E / Gardiner, Woodrow D / Doherty, Brookelyn M / Harrigan, Ryan T / Yuede, Kayla M / Yuede, Carla M / Cirrito, John R

    Brain : a journal of neurology

    2023  Volume 146, Issue 6, Page(s) 2268–2274

    Abstract: The risk of developing Alzheimer's disease is mediated by a combination of genetics and environmental factors, such as stress, sleep abnormalities and traumatic brain injury. Women are at a higher risk of developing Alzheimer's disease than men, even ... ...

    Abstract The risk of developing Alzheimer's disease is mediated by a combination of genetics and environmental factors, such as stress, sleep abnormalities and traumatic brain injury. Women are at a higher risk of developing Alzheimer's disease than men, even when controlling for differences in lifespan. Women are also more likely to report high levels of stress than men. Sex differences in response to stress may play a role in the increased risk of Alzheimer's disease in women. In this study, we use in vivo microdialysis to measure levels of Aβ in response to acute stress in male and female mice. We show that Aβ levels are altered differently between female and male mice (APP/PS1 and wild-type) in response to stress, with females showing significantly increased levels of Aβ while most males do not show a significant change. This response is mediated through β-arrestin involvement in Corticotrophin Releasing Factor receptor signalling pathway differences in male and female mice as male mice lacking β-arrestin show increase in Aβ in response to stress similar to females.
    MeSH term(s) Mice ; Female ; Male ; Animals ; Alzheimer Disease/metabolism ; Amyloid beta-Protein Precursor/metabolism ; Mice, Transgenic ; Disease Models, Animal ; Amyloid beta-Peptides/metabolism ; beta-Arrestins/metabolism ; Presenilin-1/metabolism
    Chemical Substances Amyloid beta-Protein Precursor ; Amyloid beta-Peptides ; beta-Arrestins ; Presenilin-1
    Language English
    Publishing date 2023-05-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 80072-7
    ISSN 1460-2156 ; 0006-8950
    ISSN (online) 1460-2156
    ISSN 0006-8950
    DOI 10.1093/brain/awad052
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Aging reduces motivation through decreased

    Lei, Hanyue Cecilia / Parker, Kyle E / Yuede, Carla M / McCall, Jordan G / Imai, Shin-Ichiro

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Age-associated reduced motivation is a hallmark of neuropsychiatric disorders in the elderly. In our rapidly aging societies, it is critical to keep motivation levels high enough to promote healthspan and lifespan. However, how motivation is reduced ... ...

    Abstract Age-associated reduced motivation is a hallmark of neuropsychiatric disorders in the elderly. In our rapidly aging societies, it is critical to keep motivation levels high enough to promote healthspan and lifespan. However, how motivation is reduced during aging remains unknown. Here, we used multiple mouse models to evaluate motivation and related affective states in young and old mice. We also compared the effect of social isolation, a common stressor, to those of aging. We found that both social isolation and aging decreased motivation in mice, but that
    Language English
    Publishing date 2023-01-24
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.01.19.524624
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: A role for δ subunit-containing GABA

    Lambert, Peter M / Salvatore, Sofia V / Lu, Xinguo / Shu, Hong-Jin / Benz, Ann / Rensing, Nicholas / Yuede, Carla M / Wong, Michael / Zorumski, Charles F / Mennerick, Steven

    bioRxiv : the preprint server for biology

    2024  

    Abstract: GABA : Significance statement: The impact on cortical EEG of inhibition on PV+ neurons was studied by deleting a ... ...

    Abstract GABA
    Significance statement: The impact on cortical EEG of inhibition on PV+ neurons was studied by deleting a GABA
    Language English
    Publishing date 2024-03-29
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.03.25.586604
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Kir6.2-K

    Constantino, Nicholas J / Carroll, Caitlin M / Williams, Holden C / Yuede, Carla M / Sheehan, Patrick W / Andy Snipes, J / Musiek, Erik S / Johnson, Lance A / Macauley, Shannon L

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Metabolism plays an important role in the maintenance of vigilance states (e.g. wake, NREM, and REM). Brain lactate fluctuations are a biomarker of sleep. Increased interstitial fluid (ISF) lactate levels are necessary for arousal and wake-associated ... ...

    Abstract Metabolism plays an important role in the maintenance of vigilance states (e.g. wake, NREM, and REM). Brain lactate fluctuations are a biomarker of sleep. Increased interstitial fluid (ISF) lactate levels are necessary for arousal and wake-associated behaviors, while decreased ISF lactate is required for sleep. ATP-sensitive potassium (K
    Highlights: Glycolytic flux is necessary for neurotransmitter synthesis. In its absence, neuronal activity is compromised causing changes in arousal and vigilance states despite sufficient energy availability. With Kir6.2-K
    Language English
    Publishing date 2024-02-28
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.02.23.581817
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Effects of Complete and Partial Loss of the 24S-Hydroxycholesterol-Generating Enzyme

    Shu, Hong-Jin / Ziolkowski, Luke H / Salvatore, Sofia V / Benz, Ann M / Wozniak, David F / Yuede, Carla M / Paul, Steven M / Zorumski, Charles F / Mennerick, Steven

    Biomolecules

    2024  Volume 14, Issue 3

    Abstract: Brain cholesterol metabolic products include neurosteroids and oxysterols, which play important roles in cellular physiology. In neurons, the cholesterol oxidation product, 24S-hydroxycholesterol (24S-HC), is a regulator of signaling and transcription. ... ...

    Abstract Brain cholesterol metabolic products include neurosteroids and oxysterols, which play important roles in cellular physiology. In neurons, the cholesterol oxidation product, 24S-hydroxycholesterol (24S-HC), is a regulator of signaling and transcription. Here, we examined the behavioral effects of 24S-HC loss, using global and cell-selective genetic deletion of the synthetic enzyme CYP46A1. Mice that are globally deficient in CYP46A1 exhibited hypoactivity at young ages and unexpected increases in conditioned fear memory. Despite strong reductions in hippocampal 24S-HC in mice with selective loss of CYP46A1 in VGLUT1-positive cells, behavioral effects were not recapitulated in these conditional knockout mice. Global knockout produced strong, developmentally dependent transcriptional effects on select cholesterol metabolism genes. These included paradoxical changes in Liver X Receptor targets. Again, conditional knockout was insufficient to recapitulate most changes. Overall, our results highlight the complex effects of 24S-HC in an in vivo setting that are not fully predicted by known mechanisms. The results also demonstrate that the complete inhibition of enzymatic activity may be needed for a detectable, therapeutically relevant impact on gene expression and behavior.
    MeSH term(s) Mice ; Animals ; Cholesterol 24-Hydroxylase/metabolism ; Hydroxycholesterols/metabolism ; Cholesterol/metabolism ; Hippocampus/metabolism
    Chemical Substances 24-hydroxycholesterol (47IMW63S3F) ; Cholesterol 24-Hydroxylase (EC 1.14.14.25) ; Hydroxycholesterols ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2024-02-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2701262-1
    ISSN 2218-273X ; 2218-273X
    ISSN (online) 2218-273X
    ISSN 2218-273X
    DOI 10.3390/biom14030254
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: The Hao-Fountain syndrome protein USP7 regulates neuronal connectivity in the brain via a novel p53-independent ubiquitin signaling pathway.

    Chen, Hao / Ferguson, Cole J / Mitchell, Dylan C / Titus, Amanda / Paulo, Joao A / Hwang, Andrew / Lin, Tsen-Hsuan / Yano, Hiroko / Gu, Wei / Song, Sheng-Kwei / Yuede, Carla M / Gygi, Steven P / Bonni, Azad / Kim, Albert H

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Precise control of protein ubiquitination is essential for brain development, and hence, disruption of ubiquitin signaling networks can lead to neurological disorders. Mutations of the deubiquitinase USP7 cause the Hao-Fountain syndrome (HAFOUS), ... ...

    Abstract Precise control of protein ubiquitination is essential for brain development, and hence, disruption of ubiquitin signaling networks can lead to neurological disorders. Mutations of the deubiquitinase USP7 cause the Hao-Fountain syndrome (HAFOUS), characterized by developmental delay, intellectual disability, autism, and aggressive behavior. Here, we report that conditional deletion of USP7 in excitatory neurons in the mouse forebrain triggers diverse phenotypes including sensorimotor deficits, learning and memory impairment, and aggressive behavior, resembling clinical features of HAFOUS. USP7 deletion induces neuronal apoptosis in a manner dependent of the tumor suppressor p53. However, most behavioral abnormalities in USP7 conditional mice persist despite p53 loss. Strikingly, USP7 deletion in the brain perturbs the synaptic proteome and dendritic spine morphogenesis independently of p53. Integrated proteomics analysis reveals that the neuronal USP7 interactome is enriched for proteins implicated in neurodevelopmental disorders and specifically identifies the RNA splicing factor Ppil4 as a novel neuronal substrate of USP7. Knockdown of Ppil4 in cortical neurons impairs dendritic spine morphogenesis, phenocopying the effect of USP7 loss on dendritic spines. These findings reveal a novel USP7-Ppil4 ubiquitin signaling link that regulates neuronal connectivity in the developing brain, with implications for our understanding of the pathogenesis of HAFOUS and other neurodevelopmental disorders.
    Language English
    Publishing date 2024-01-13
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.10.24.563880
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB.

    McCullough, Katherine B / Titus, Amanda / Reardon, Kate / Conyers, Sara / Dougherty, Joseph D / Ge, Xia / Garbow, Joel R / Dickson, Patricia / Yuede, Carla M / Maloney, Susan E

    Journal of neurodevelopmental disorders

    2024  Volume 16, Issue 1, Page(s) 16

    Abstract: Background: Mucopolysaccharidosis (MPS) IIIB, also known as Sanfilippo Syndrome B, is a devastating childhood disease. Unfortunately, there are currently no available treatments for MPS IIIB patients. Yet, animal models of lysosomal storage diseases ... ...

    Abstract Background: Mucopolysaccharidosis (MPS) IIIB, also known as Sanfilippo Syndrome B, is a devastating childhood disease. Unfortunately, there are currently no available treatments for MPS IIIB patients. Yet, animal models of lysosomal storage diseases have been valuable tools in identifying promising avenues of treatment. Enzyme replacement therapy, gene therapy, and bone marrow transplant have all shown efficacy in the MPS IIIB model systems. A ubiquitous finding across rodent models of lysosomal storage diseases is that the best treatment outcomes resulted from intervention prior to symptom onset. Therefore, the aim of the current study was to identify early markers of disease in the MPS IIIB mouse model as well as examine clinically-relevant behavioral domains not yet explored in this model.
    Methods: Using the MPS IIIB mouse model, we explored early developmental trajectories of communication and gait, and later social behavior, fear-related startle and conditioning, and visual capabilities. In addition, we examined brain structure and function via magnetic resonance imaging and diffusion tensor imaging.
    Results: We observed reduced maternal isolation-induced ultrasonic vocalizations in MPS IIIB mice relative to controls, as well as disruption in a number of the spectrotemporal features. MPS IIIB also exhibited disrupted thermoregulation during the first two postnatal weeks without any differences in body weight. The developmental trajectories of gait were largely normal. In early adulthood, we observed intact visual acuity and sociability yet a more submissive phenotype, increased aggressive behavior, and decreased social sniffing relative to controls. MPS IIIB mice showed greater inhibition of startle in response to a pretone with a decrease in overall startle response and reduced cued fear memory. MPS IIIB also weighed significantly more than controls throughout adulthood and showed larger whole brain volumes and normalized regional volumes with intact tissue integrity as measured with magnetic resonance and diffusion tensor imaging, respectively.
    Conclusions: Together, these results indicate disease markers are present as early as the first two weeks postnatal in this model. Further, this model recapitulates social, sensory and fear-related clinical features. Our study using a mouse model of MPS IIIB provides essential baseline information that will be useful in future evaluations of potential treatments.
    MeSH term(s) Humans ; Animals ; Adult ; Child ; Mucopolysaccharidosis III/genetics ; Mucopolysaccharidosis III/pathology ; Diffusion Tensor Imaging ; Brain ; Disease Models, Animal ; Treatment Outcome
    Language English
    Publishing date 2024-04-17
    Publishing country England
    Document type Journal Article
    ZDB-ID 2487174-6
    ISSN 1866-1955 ; 1866-1955
    ISSN (online) 1866-1955
    ISSN 1866-1955
    DOI 10.1186/s11689-024-09534-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Exercise Training Results in Lower Amyloid Plaque Load and Greater Cognitive Function in an Intensity Dependent Manner in the Tg2576 Mouse Model of Alzheimer's Disease.

    Thomas, Riya / Zimmerman, Scott D / Yuede, Kayla M / Cirrito, John R / Tai, Leon M / Timson, Benjamin F / Yuede, Carla M

    Brain sciences

    2020  Volume 10, Issue 2

    Abstract: Three months of exercise training (ET) decreases soluble ... ...

    Abstract Three months of exercise training (ET) decreases soluble Aβ
    Language English
    Publishing date 2020-02-08
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2651993-8
    ISSN 2076-3425
    ISSN 2076-3425
    DOI 10.3390/brainsci10020088
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Aqp4 stop codon readthrough facilitates amyloid-β clearance from the brain.

    Sapkota, Darshan / Florian, Colin / Doherty, Brookelyn M / White, Kelli M / Reardon, Kate M / Ge, Xia / Garbow, Joel R / Yuede, Carla M / Cirrito, John R / Dougherty, Joseph D

    Brain : a journal of neurology

    2023  Volume 145, Issue 9, Page(s) 2982–2990

    Abstract: Alzheimer's disease is initiated by the toxic aggregation of amyloid-β. Immunotherapeutics aimed at reducing amyloid beta are in clinical trials but with very limited success to date. Identification of orthogonal approaches for clearing amyloid beta may ... ...

    Abstract Alzheimer's disease is initiated by the toxic aggregation of amyloid-β. Immunotherapeutics aimed at reducing amyloid beta are in clinical trials but with very limited success to date. Identification of orthogonal approaches for clearing amyloid beta may complement these approaches for treating Alzheimer's disease. In the brain, the astrocytic water channel Aquaporin 4 is involved in clearance of amyloid beta, and the fraction of Aquaporin 4 found perivascularly is decreased in Alzheimer's disease. Further, an unusual stop codon readthrough event generates a conserved C-terminally elongated variant of Aquaporin 4 (AQP4X), which is exclusively perivascular. However, it is unclear whether the AQP4X variant specifically mediates amyloid beta clearance. Here, using Aquaporin 4 readthrough-specific knockout mice that still express normal Aquaporin 4, we determine that this isoform indeed mediates amyloid beta clearance. Further, with high-throughput screening and counterscreening, we identify small molecule compounds that enhance readthrough of the Aquaporin 4 sequence and validate a subset on endogenous astrocyte Aquaporin 4. Finally, we demonstrate these compounds enhance brain amyloid-β clearance in vivo, which depends on AQP4X. This suggests derivatives of these compounds may provide a viable pharmaceutical approach to enhance clearance of amyloid beta and potentially other aggregating proteins in neurodegenerative disease.
    MeSH term(s) Alzheimer Disease/metabolism ; Amyloid beta-Peptides/metabolism ; Animals ; Aquaporin 4/genetics ; Aquaporin 4/metabolism ; Brain/metabolism ; Codon, Terminator ; Mice ; Neurodegenerative Diseases/metabolism
    Chemical Substances Amyloid beta-Peptides ; Aqp4 protein, mouse ; Aquaporin 4 ; Codon, Terminator
    Language English
    Publishing date 2023-08-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80072-7
    ISSN 1460-2156 ; 0006-8950
    ISSN (online) 1460-2156
    ISSN 0006-8950
    DOI 10.1093/brain/awac199
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: An electrochemical approach for rapid, sensitive, and selective detection of dynorphin.

    Conway, Sineadh M / Kuo, Chao-Cheng / Gardiner, Woodrow / Wu, Rui-Ni / Thang, Loc V / Gereau, Graydon B / Cirrito, John R / Yuede, Carla M / McCall, Jordan G / Al-Hasani, Ream

    bioRxiv : the preprint server for biology

    2023  

    Abstract: The endogenous opioid peptide systems are critical for analgesia, reward processing, and affect, but research on their release dynamics and function has been challenging. Here, we have developed microimmunoelectrodes (MIEs) for the electrochemical ... ...

    Abstract The endogenous opioid peptide systems are critical for analgesia, reward processing, and affect, but research on their release dynamics and function has been challenging. Here, we have developed microimmunoelectrodes (MIEs) for the electrochemical detection of opioid peptides using square-wave voltammetry. Briefly, a voltage is applied to the electrode to cause oxidation of the tyrosine residue on the opioid peptide of interest, which is detected as current. To provide selectivity to these voltammetric measurements, the carbon fiber surface of the MIE is coated with an antiserum selective to the opioid peptide of interest. To test the sensitivity of the MIEs, electrodes are immersed in solutions containing different concentrations of opioid peptides, and peak oxidative current is measured. We show that dynorphin antiserum-coated electrodes are sensitive to increasing concentrations of dynorphin in the attomolar range. To confirm selectivity, we also measured the oxidative current from exposure to tyrosine and other opioid peptides in solution. Our data show that dynorphin antiserum-coated MIEs are sensitive and selective for dynorphin with little to no oxidative current observed in met-enkephalin and tyrosine solutions. Additionally, we demonstrate the utility of these MIEs in an
    Language English
    Publishing date 2023-02-03
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.02.01.526701
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top